Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

SUMMARY: Bone mineral density (BMD) sometimes cannot be improved by long-term bisphosphonate (BP) therapy in osteoporosis (OP). This study showed that lumbar as well as hip BMD significantly increased after denosumab treatment in patients not responsive to BPs. Thus, denosumab may be a strong OP tre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Osteoporos Int
Main Authors: Kamimura, M., Nakamura, Y., Ikegami, S., Uchiyama, S., Kato, H., Taguchi, A.
Format: Artigo
Sprog:Inglês
Udgivet: Springer London 2016
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5269470/
https://ncbi.nlm.nih.gov/pubmed/27650642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-016-3764-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker